Journal
LIFE SCIENCES
Volume 191, Issue -, Pages 90-96Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2017.10.015
Keywords
alpha(1)-Adrenoceptor blocker; Benign prostatic hyperplasia; Partial bladder outlet obstruction; Micturition reflex; Storage symptom
Ask authors/readers for more resources
Elderly patients suffering from lower urinary tract symptoms with benign prostatic hyperplasia (BPH) are widely prescribed alpha(1)-adrenoceptor blockers (alpha(1)-blockers) to improve voiding and storage symptoms. The mechanism of action for improvements in voiding symptoms is well understood; tonus of the urethra and prostate are decreased and urinary flow rate is increased by alpha(1)-blockers. However, the mechanisms underlying storage symptoms have remained unclear, although detrusor hyperactivity has been identified as a significant factor. Previous investigations have yielded informative results, such as amelioration of reduced blood flow and afferent C-fiber activation, and the importance of the urothelium. Recently, the fascinating role of alpha(1A)- and alpha(1D)-adrenoceptor subtypes have been investigated for bladder function. Furthermore, the scope of this pathology covers both the bladder and that part of the central nervous system related to the micturition reflex. This review describes the beneficial effects of alpha(1)-blockers on storage symptoms and the pathogenesis of storage symptoms related to BPH, discusses the mechanisms of action for alpha(1)-blockers with reference to results from cystometry to suggest improvements in management that suppress detrusor hyperactivity, and examines the potential influence of alpha(1A)- and alpha(1D)-adrenoceptor subtypes on bladder activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available